TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
Conditions: Hepatocellular Carcinoma; Hepatic Portal Vein Tumor Invasion; Tumor Thrombus Interventions: Procedure: I-125 Seeds Brachytherapy in PVTT; Procedure: Transcatheter arterial chemoembolization; Drug: Atezolizumab plus Bevacizumab Sponsors: Third Affiliated Hospital, Sun Yat-Sen University; Sun Yat-sen University; Fifth Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital of Guangzhou Medical University; Maoming People's Hospital; Shandong Provincial Third Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Brachytherapy | Cancer & Oncology | Carcinoma | Hospitals | Research | Thrombosis